Related Experiment Video
Updated: Aug 11, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
Published on: September 10, 2016
Designer probiotics for prevention of enteric infections
Adrienne W Paton1, Renato Morona, James C Paton
1School of Molecular and Biomedical Science, University of Adelaide, South Australia, 5005, Australia.
Abstract:
Many microbial pathogens, including those responsible for major enteric infections, exploit oligosaccharides that are displayed on the surface of host cells as receptors for toxins and adhesins. Blocking crucial ligand-receptor interactions is therefore a promising therapeutic strategy. One approach is to express molecular mimics of host receptors on the surface of harmless recombinant bacteria that can survive in the gut. These 'designer probiotics' bind bacterial toxins in the gut lumen with very high avidity, thereby preventing disease. This article discusses recent progress with this strategy.
Related Concept Videos
Probiotics
Microbiota Modulation by Antibiotics
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Dysbiosis of the Gut Microbiota
Development of Human Microbiota
Microbes in the Production of Fermented Foods
